Saha Sanu, Auddy Sourya Shankar, Chatterjee Akash, Sen Prosenjit, Goswami Rajib Kumar
Org Lett. 2022 Oct 7;24(39):7113-7117. doi: 10.1021/acs.orglett.2c02699. Epub 2022 Sep 23.
Asymmetric total synthesis of cyclotetradepsipeptide beauveamide A has been achieved for the first time. A macrolactamization strategy involving two possible sites has been explored to find the most effective route for cyclization. A late-stage functionalization approach has been adopted for easy access of non-natural analogues of beauveamide A for further biological evaluation. Interestingly, the anticancer activity of one of the synthesized analogues was better than that of the parent natural product.
首次实现了环四肽缩酚酸肽波弗酰胺A的不对称全合成。探索了一种涉及两个可能位点的大环内酰胺化策略,以找到最有效的环化途径。采用了后期功能化方法,以便轻松获得波弗酰胺A的非天然类似物,用于进一步的生物学评估。有趣的是,其中一种合成类似物的抗癌活性优于母体天然产物。